Pamela Borges

Dr. Pamela Borges

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Nature
Verified
Journal Article
Closed access
PDF file
HTHiroyuki Takai
Hiroyuki Takai
VAValentina Aria
Valentina Aria
PBPamela Borges
Pamela Borges
JYJoseph T. P. Yeeles
Joseph T. P. Yeeles
TLTitia de Lange
Titia de Lange

11 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
PBPamela Borges
Pamela Borges
CBChaïnez Bouabboune
Chaïnez Bouabboune
JEJose Miguel Escandell
Jose Miguel Escandell
SMSamah Matmati
Samah Matmati
SCStephane Coulon
Stephane Coulon
Miguel Godinho FerreiraMiguel Godinho Ferreira
Miguel Godinho Ferreira
Telomeres are nucleoprotein complexes that protect the chromosome-ends from eliciting DNA repair while ensuring their complete duplication. Pot1 is a subunit of telomere capping complex that binds to the G-rich overhang and inhibits the activation of DNA damage checkpoints. In this study, we explore new functions of fission yeast Pot1 by using a pot1-1 temperature sensitive mutant. We show that pot1 inactivation impairs telomere DNA replication resulting in the accumulation of ssDNA leading to the complete loss of telomeric DNA. Recruitment of Stn1 to telomeres, an auxiliary factor of DNA lagging strand synthesis, is reduced in pot1-1 mutants and overexpression of Stn1 rescues loss of telomeres and cell viability at restrictive temperature. We propose that Pot1 plays a crucial function in telomere DNA replication by recruiting Stn1-Ten1 and Polα-primase complex to telomeres via Tpz1, thus promoting lagging-strand DNA synthesis at stalled replication forks.

24 November 2025 in Genes
Verified
Journal Article
Open access
PDF file
CSCarla S.dos Santos
Carla S.dos Santos
AMAna Cristina Magalhaes
Ana Cristina Magalhaes
RPRicardo J. Pinto
Ricardo J. Pinto
CCCarla Carrilho
Carla Carrilho
CPCláudia Pereira
Cláudia Pereira
LPLuisa Luisa Pereira
Luisa Luisa Pereira
Cancer is an increasing public health burden, including in Sub-Saharan African (SSA) populations, where cancer incidence is predicted to increase by around 140% between 2022 and 2050. These rates require a better understanding of the epidemiological, clinical, and genetic/molecular characteristics of cancer in SSA populations. There is an urgent need to improve the genomic characterization of SSA tumour samples and also to establish suitable in vitro models for hypothesis testing. In fact, even though thousands of cancer cell lines (CCLs) have been established employing different methods of cell immortalization and have been included in deep molecular characterization panels, SSA ancestry is limited to only ~6% (mostly African Americans, who represent limited diversity in the context of the African continent) of publicly available CCLs. This disparity needs to be addressed by using next-generation immortalization methods such as conditional reprogramming to establish CCLs derived from SSA cancer patients that also represent the diversity within the African continent. Research in SSA oncobiology has the potential to add essential information to better understand the diverse molecular pathways leading to cancer and to find promising therapeutic avenues. We also discuss the challenges to conducting oncobiology studies with cell modelling derived from SSA patients in low-to-middle-income African countries, such as Portuguese-speaking African countries.

1 February 2026 in JCO Global Oncology
Verified
Journal Article
Closed access
PBPamela Borges
Pamela Borges
VCVictor Costa
Victor Costa
HSHirondina Borges Spencer
Hirondina Borges Spencer
PLPedro Leite-Silva
Pedro Leite-Silva
SFStefani Furtado
Stefani Furtado
Lúcio Lara SantosLúcio Lara Santos
Lúcio Lara Santos
PURPOSE: Breast cancer (BC) is becoming a significant public health issue in Cape Verde. Understanding the profile of BC cases is crucial for improving patient outcomes and guiding public health initiatives. This study aimed to investigate the clinical and pathologic characteristics, treatment approaches, and outcomes of BC cases diagnosed and treated at Agostinho Neto University Hospital between January 2015 and July 2021 following implementation of an international treatment partnership. METHODS: A retrospective analysis was conducted on 158 female patients with BC diagnosed during the study period. Data were collected on patient demographics, tumor characteristics, treatment protocols, and survival outcomes. Immunohistochemistry was performed on a subset of 114 patients to identify molecular subtypes. Descriptive statistics were used to summarize all variables. Overall survival was analyzed, and log-rank tests were performed to formally compare the survival curves and assess the statistical significance of any observed differences. Cox proportional hazard models were used to determine the independent effect of sociodemographic factors and clinical characteristics. RESULTS: The median age at diagnosis was 52.5 years, with patients ranging from 28 to 91 years. Most patients resided on Santiago Island. Invasive ductal carcinoma was the most common type, found in 93% of cases. Over half of the tumors were poorly differentiated, and 57% were diagnosed at advanced stages (III and IV). Subtype distribution mirrored sub-Saharan patterns, with 24% triple negative and 11% human epidermal growth factor receptor 2 positive. Among patients with potentially curable BC, 61.4% received adequate therapy that followed the National Comprehensive Cancer Network (NCCN) Harmonized Guidelines for sub-Saharan Africa (SSA), including radiotherapy treatment, although this was performed abroad. The median follow-up calculated by reverse Kaplan-Meier was 33.7 months (IQR, 20.5-52.8 months). Patients treated according to stage-appropriate and phenotype-specific recommendations achieved better outcomes (79.9% 3-year survival). CONCLUSION: This study emphasizes the importance of early diagnosis and adoption of the NCCN Harmonized Guidelines for SSA. Access to radiotherapy abroad, necessitated by the absence of local radiotherapy facilities, was correlated with improved survival. These findings underscore the feasibility of improving outcomes in low-resource settings through standardized treatment frameworks.

23 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
PBPamela Borges
Pamela Borges
JEJose Miguel Escandell
Jose Miguel Escandell
SMSamah Matmati
Samah Matmati
SCStephane Coulon
Stephane Coulon
Miguel Godinho FerreiraMiguel Godinho Ferreira
Miguel Godinho Ferreira
Telomeres are nucleoprotein complexes that protect the chromosome-ends from eliciting DNA repair while ensuring their complete duplication. Pot1 is a subunit of telomere capping complex that binds to the G-rich overhang and inhibits the activation of DNA damage checkpoints. In this study, we explore new functions of fission yeast Pot1 by using a pot1-1 temperature sensitive mutant. We show that pot1 inactivation impairs telomere DNA replication resulting in the accumulation of ssDNA leading to the complete loss of telomeric DNA. Recruitment of Stn1 to telomeres, an auxiliary factor of DNA lagging strand synthesis, is reduced in pot1-1 mutants and overexpression of Stn1 rescues loss of telomeres and cell viability at restrictive temperature. We propose that Pot1 plays a crucial function in telomere DNA replication by recruiting Stn1-Ten1 and Polα-primase complex to telomeres, thus promoting lagging-strand DNA synthesis at stalled replication forks.